The future of epidemiology

Academic Medicine

Volumn 84, Issue 11, 2009, Pages 1631-1637

  Ness, Roberta B ^a   Andrews, Elizabeth B ^b   Gaudino, James A ^c   Newman, Anne B ^d   Soskolne, Colin L ^e   Stürmer, Til ^f   Wartenberg, Daniel E ^g   Weiss, Stanley H ^h  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b RTI HEALTH SOLUTIONS   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f IL   (United States)

^g RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^h RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; AGING; DATA ANALYSIS; DEMOGRAPHY; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; GENOMICS; HUMAN; INFECTION; LIFESTYLE; METHODOLOGY; OBESITY; OUTCOMES RESEARCH; POVERTY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; RESEARCH; RESEARCH ETHICS; REVIEW; RISK FACTOR;

EID: 70449436134     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACM.0b013e3181bbb4ed     Document Type: Review

References (65)

1. Centers for Disease Control and Prevention. Chronic Disease Prevention and Health Promotion. Available at: (http://www.cdc.gov/ nccdphp). Accessed July 19, 2009.
2. Taubes G. Unhealthy science. Why can't we trust much of what we hear about diet, health and behavior-related diseases? The New York Times Magazine. September 16, 2007:52.
3. Ness RB, Rothenberg R. Critique of epidemiology: Changing the terms of the debate. Ann Epidemiol. 2007;17:1011-1012.
4. Ness RB, Koopman JS, Roberts MS. Causal system modeling in chronic disease epidemiology: A proposal. Ann Epidemiol. 2007;17:564-568.
5. Halloran ME, Ferguson NM, Eubank S, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A. 2008;105:4639-4644.
6. Eddy DM, Schlessinger L. Archimedes: A trial-validated model of diabetes. Diabetes Care. 2003;26:3168-3171.
7. U.S. Department of Health and Human Services. Health information privacy. Available at: (http://www.dhhs.gov/ocr/privacy/hipaa/ understanding/index.html) . Accessed July 19, 2009.
8. Ness RB; Joint Policy Committee, Societies of Epidemiology. Influence of the HIPAA Privacy Rule on health research. JAMA. 2007; 298:2164-2170.
9. Ness RB. A year is a terrible thing to waste: Early experience with HIPAA. Ann Epidemiol. 2005;15:85-86.
10. U.S. Department of Education. Family Educational Rights and Privacy Act (FERPA). Available at: (http://www.ed.gov/policy/gen/ guid/fpco/ferpa/index. html). Accessed July 19, 2009.
11. Soskolne CL. Epidemiological research, interest groups, and the review process. J Public Health Policy. 1985;6:173-184.
12. Beauchamp TL, Cook RL, Fayerweather WE, et al. Ethical guidelines for epidemiologists. J Clin Epidemiol. 1991;44(suppl 1):151S- 169S.
13. Soskolne CL, Light A. Towards ethics guidelines for environmental epidemiologists. Sci Total Environ. 1996;184:137-147.
14. American College of Epidemiology ethics guidelines. Ann Epidemiol. 2000;10:487-497.
15. Council for International Organizations of Medical Sciences (CIOMS). International Ethical Guidelines for Epidemiologic Studies. Geneva, Switzerland: CIOMS; 2009.
16. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 5th ed. New York, NY: Oxford University Press; 2001.
17. Soskolne CL, Abbrecht PH, Davidian NM, Price AR. Good conduct and integrity in epidemiologic research. In: Coughlin SS, Beauchamp TL, Weed DL, eds. Ethics and Epidemiology. 2nd ed. New York, NY: Oxford University Press; 2009:264-282.
18. Soskolne CL. On the even greater need for precaution under global change. Hum Ecol Risk Assess. 2005;11:97-106.
19. World Health Organization. Commission on Social Determinants of Health. Closing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health. Available at: (http://whqlibdoc.who.int/publications/ 2008/9789241563703-eng.pdf). Accessed July 19, 2009.
20. World Health Organization. The World Health Report 2000: Health Systems: Improving Performance. Available at: (http:// www.who.int/whr/2000/en/whr00-en. pdf). Accessed July 19, 2009.
21. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, Office of Human Subjects Research, National Institutes of Health. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: Department of Health, Education, and Welfare; 1979. Publication No. (OS) 78-0013 and No. (OS) 78-10014, Superintendent of Documents, U.S. Government Printing Office.
22. Soskolne CL, Sieswerda LE. Implementing ethics in the professions: Examples from environmental epidemiology. Sci Eng Ethics. 2003;9:181-190.
23. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007;9:665-674.
24. Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of prospective cohort studies. Nat Rev Genet. 2006;7:812-820.
25. Herbst AL, Robboy SJ, Scully RE, Poskanzer DC. Clear cell adenocarcinoma of the vagina and cervix in girls: An analysis of 170 registry cases. Am J Obstet Gynecol. 1974;119:713-724.
26. Herbst AL, Poskanzer DC, Robboy SJ, Friedlander L, Scully RE. Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med. 1975;292:334-339.
27. Hurwitz ES, Barrett MJ, Bregman D, et al. Public Health Service study of Reye's syndrome and medications. Report of the main study. JAMA. 1987;257:1905-1911.
28. Holmes LB. Teratogen update: Bendectin. Teratology. 1983;27:277-281.
29. McKeigue PM, Lamm SH, Linn S, Kutcher JS. Bendectin and birth defects: I. A metaanalysis of the epidemiologic studies. Teratology. 1994;50:27-37.
30. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA. 1993; 269:1257-1261. (Pubitemid 23067428)
31. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of betablockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115-121.
32. Committee on the Assessment of the US Drug Safety System; Board on Population Health and Public Health Practice; Baciu A, Stratton K, Burke SP, eds. Institute of Medicine of the National Academies. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, DC: The National Academies Press; 2007.
33. Department for International Development. Millennium development goals. Available at: (http://www.dfid.gov.uk/mdg). Accessed July 19, 2009.
34. Global Forum for Health Research: Helping Correct the 10/90 Gap. 10/90 Report on Health Research 2003-2004. Available at: (http://www. globalforumhealth.org/Media- Publications/Publications/10-90-Report- 2003-2004). Accessed July 19, 2009.
35. Soskolne CL, Butler CD, Ijsselmuiden C, London L, von Schirnding Y. Toward a global agenda for research in environmental epidemiology. Epidemiology. 2007;18:162-166.
36. World Health Organization. Obesity and overweight. Available at: (http://www.who.int/ mediacentre/factsheets/fs311/en/index.html). Accessed July 19, 2009.
37. Centers for Disease Control and Prevention. U.S. obesity trends: Trends by state 1985-2007. Available at: (http://www.cdc.gov/nccdphp/ dnpa/obesity/trend/maps). Accessed July 19, 2009.
38. Manton KG, Gu X. Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999. Proc Natl Acad Sci U S A. 2001;98:6354-6359.
39. Karlamangla A, Tinetti M, Guralnik J, Studenski S, Wetle T, Reuben D. Comorbidity in older adults: Nosology of impairment, diseases, and conditions. J Gerontol A Biol Sci Med Sci. 2007;62:296-300.
40. Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281:558-560.
41. Newman AB, Arnold AM, Sachs MC, et al. Long-term function in an older cohort-The cardiovascular health study all stars study. J Am Geriatr Soc. 2009;57:432-440.
42. Newman AB, Simonsick EM, Naydeck BL, et al. Association of long distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA. 2006;295:2018-2026.
43. Rosano C, Newman AB, Katz R, Hirsch CH, Kuller LH. Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in wellfunctioning older adults. J Am Geriatr Soc. 2008;56:1618-1625.
44. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34:541-554.
45. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
46. Semba RD, Ferrucci L, Sun K, et al. Oxidative stress is associated with greater mortality in older women living in the community. J Am Geriatr Soc. 2007;55:1421-1425. (Pubitemid 47329247)
47. Cappola AR, Xue QL, Ferrucci L, Guralnik JM, Volpato S, Fried LP. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab. 2003; 88:2019-2025.
48. Weiss SH. Searching for new infectious agents using modern molecular biology. Presented at: 2nd North American Congress of Epidemiology; June 24, 2006; Seattle, Wash.
49. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA. Evidence for heritable predisposition to death due to influenza. J Infect Dis. 2008;197:18-24.
50. Mubareka S, Palese P. Human genes and influenza. J Infect Dis. 2008;197:1-3.
51. Fredricks DN, Relman DA. Sequence-based identification of microbial pathogens: A reconsideration of Koch's postulates. Clin Microbiol Rev. 1996;9:18-33.
52. Weiss SH, Cowan EP. Laboratory detection of human retroviruses. In: Wormser GP, ed. AIDS and Other Manifestations of HIV Infection. 4th ed. London, UK: Elsevier Science; 2004:147-183.
53. Hyytiä-Trees E, Smole SC, Fields PA, Swaminathan B, Ribot EM. Second generation subtyping: A proposed PulseNet protocol for multiple-locus variable-number tandem repeat analysis of Shiga toxinproducing Escherichia coli O157 (STEC O157). Foodborne Pathog Dis. 2006;3:118-131.
54. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527. (Pubitemid 36159887)
55. Centers for Disease Control and Prevention. Update: Measles-United States, January-July 2008.MMWRMorb Mortal Wkly Rep. 2008; 57:893-896. Available at: (http://www.cdc.gov/ mmwr/preview/mmwrhtml/mm5733a1.htm). Accessed July 19, 2009.
56. Centers for Disease Control and Prevention. Outbreak of Salmonella serotype Saintpaul infections associated with multiple raw produce items-United States, 2008. MMWR Morb Mortal Wkly Rep. 2008;57:929 -934. Available at: (http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm5734a1.htm). Accessed July 19, 2009.
57. Centers for Disease Control and Prevention. Multistate outbreak of Salmonella infections associated with peanut butter and peanut butter-containing products-United States, 2008-2009.MMWRMorb Mortal Wkly Rep. 2009;58:85-90. Available at: (http://www.cdc. gov/mmwr/preview/mmwrhtml/mm5804a4. htm). Accessed July 19, 2009.
58. Yoder JS, Hlavsa MC, Craun GF, et al. Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events-United States, 2005-2006. MMWR Surveill Summ. 2008;57:1-29. Available at: (http://www.cdc.gov/mmwr/ preview/mmwrhtml/ss5709a1. htm). Accessed July 19, 2009.
59. Frumkin H, Hess J, Luber G, Malilay J, McGeehin M. Climate change: The public health response. Am J Public Health. 2008;98: 435-445.
60. Gage KG, Burkot TR, Eisen RJ, Hayes EB. Climate and vectorborne diseases. Am J Prev Med. 2008;35:436-450.
61. Patz JA, Vavrus SJ, Uejio CK, McLellan SL. Climate change and waterborne disease risk in the Great Lakes region of the U.S. Am J Prev Med. 2008;35:451-458.
62. Thacker SB; Centers for Disease Control and Prevention. Epidemiology and Public Health at CDC. MMWR Morb Mortal Wkly Rep. 2006;55(suppl 2):3-4.
63. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355-1359.
64. Fredricks DN, Jolley JA, Lepp PW, Kosek JC, Relman DA. Rhinosporidium seeberi: A human pathogen from a novel group of aquatic protistan parasites. Emerg Infect Dis. 2000;6:273-282.
65. Fredricks D. Molecular detection of novel pathogens: New tools for understanding epidemiology and pathogenesis. Presented at: 2nd North American Congress of Epidemiology; June 24, 2006; Seattle, Wash.